Conditions: Chronic Obstructive Pulmonary Disease
Keywords: QVA149 COPD combination bronchodilator
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 339
Healthy volunteers: no

Brief summary:
The study is designed to provide long-term safety data for QVA149 in patients with moderate to severe chronic obstructive pulmonary disease (COPD).

Detailed description:

Arms:
arm 1: 110µg/50µg capsule for oral inhalation, once daily, delivered by a single dose dry powder inhaler (SDDPI) arm 2: Placebo to match QVA149, capsules for inhalation once daily, delivered by an SDDPI

Interventions: intervention 1: QVA149 intervention 2: Placebo
Intervention descriptions: intervention 1: capsules for inhalation, delivered by an SDDPI intervention 2: capsules for inhalation, delivered by an SDDPI

Protocol document: